GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Crucell Nv (CRXLY) [hlAlert]

Rating:
Buy CRXL
up 59.52 %

Crucell Nv (CRXL) upgraded to Buy by UBS

Posted on: Monday,  Apr 19, 2010  8:25 AM ET by UBS

UBS rated Buy Crucell Nv (OTCBB: CRXLY) on 04/19/2010, when the stock price was $20.26. Since
then, Crucell Nv has gained 59.53% as of 03/19/2012's recent price of $32.32.
If you would have followed this UBS's recommendation on CRXLY, you would have gained 59.52% of your investment in 700 days.

Crucell N.V. discovers, develops, and produces a variety of biopharmaceuticals for the treatment of human diseases. Unlike the technologies generally employed in the biopharmaceutical industry, the company's technologies are fully-human and, as such, enable biopharmaceuticals to be developed and produced that do not have the limitations inherent in many biopharmaceuticals currently available.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/19/2010 8:25 AM Buy
None
20.26
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2010 8:25 AM Hold
None
19.15
11/5/2009 9:25 AM Buy
None
21.22
8/20/2009 8:25 AM Hold
None
22.42
6/15/2009 8:25 AM Buy
None
22.87

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy